Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/6/14  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Jacob M. Rowe

Wrong Prof. Jacob M. Rowe?

Adjunct Professor At the Departme...

Phone: (847) ***-****  HQ Phone
Local Address: Chicago, Illinois, United States
Northwestern University
633 Clark Street
Evanston , Illinois 60208
United States

Company Description: Founded in 1851, Northwestern University is a leading private research and teaching university with an enrollment of approximately 8,000 full-time undergraduate...   more

Employment History

Board Memberships and Affiliations


  • M.D.
  • undergraduate and medical degrees
    University College
  • MD
57 Total References
Web References
Scientific Advisory Board | StemRad, 6 Nov 2014 [cached]
Prof. Jacob M. Rowe, MD is Head of the Department of Hematology and Bone Marrow Transplantation at the Rambam Medical Center in Haifa, and is the incumbent Dresner Professor of Hemato-Oncology at the Rappaport Faculty of Medicine at the Technion, Israel Institute of Technology in Haifa. He is also an Adjunct Professor at the Department of Medicine of Northwestern University, Chicago, Illinois. Dr. Rowe has actively participated in a wide range of national and international research projects and initiatives. He is a former Chairman of the Leukemia Committee of the Eastern Cooperative Oncology Group and has developed and chaired many phase II and III studies on leukemia, lymphoma and BMT. Dr. Rowe is a frequently invited speaker or chair at international meetings and has published 250 peer-reviewed articles, reviews and book chapters. Dr. Rowe received his undergraduate and medical degrees from University College and University College Hospital in London. He completed his internship in London and did a Fellowship in Hematology/Oncology at the University of Rochester in New York. Dr. Rowe was Director of Clinical Services of the Hematology Unit at the University of Rochester Medical Center. He was also the founding director of the Bone Marrow Transplant Program at the University of Rochester.
Tip Reporter Profile of PLRS, 5 Sept 2003 [cached]
Prof. Jacob M. Rowe is a Senior Advisor to the Company.He is Chief of the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, and former Director of Clinical Services in the Hematology Unit at the University of Rochester Medical Center, NY.
Pluristem Life Systems, Inc, a biotechnology company focusing on proprietary technology to expand stem cells for treatment of genetic, metabolic and blood diseases such as leukemia, lymphoma, sickle cell anemia and immunodeficiencies, today announced that Prof. Jacob Rowe, F.A.C.P. has been appointed Chairman of the Company's Scientific Advisory Board.
Prof. Rowe is presently Chief of the Department of Hematology and Bone Marrow Transplantation at Rambam Medical Center in Haifa, Israel.Concurrently, he is a Professor of Hemato-Oncology/Bruce Rappaport Faculty of Medicine, at Technion, Israel Institute of Technology in Haifa, Israel; former Adjunct Professor of Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, NY and a Visiting Professor at Northwestern University in Chicago, IL.
Among many significant hospital and administrative appointments, Prof. Rowe is a member of the American Society of Hematology (ASH); the Appeals Committee, Hematology for the Israel Ministry of Health; a member of the Hematology Committee, Scientific Council for the Israel Medical Association; a member of the National Oncology Council, Sub-committee on Bone Marrow Transplantation, National Oncology Council, Israel; American Society for Blood and Marrow Transplantation.He has also served as Chairman of the Eastern Cooperative Oncology Group, Leukemia Committee, Bone Marrow Transplantation Core Committee,.Additionally, at Strong Memorial Hospital, Prof. Rowe was a member of the Blood Utilization Committee, House Officer Advisory Committee, Infection Control Committee, Chairman of the Task Force on Implementation of Bone Marrow Transplantation, Director of Clinical Services, Hematology Unit, and Acting Director - Bone Marrow Transplantation Program.
Prof. Rowe has conducted research and clinical trials in blood related malignancies utilizing grants from the National Institute of Health (NIH) and the National Cancer Institute (NCI) and holds a number of Faculty appointments at leading teaching medical institutions.
He is a graduate of the University College of Medicine in London.Prof. Rowe was granted an B.Sc. in Pharmacology form the University College of London (first class honors) in 1972 and an M.B., B.S. from the University College Hospital Medical School in Clinical Medicine in 1975.
"We are honored that Prof. Rowe has accepted the appointment as Chairman of Pluristem's Scientific Advisory Board.
Acute Lymphoblastic Leukemia in Adults: Advances and Challenges | Press Release | Rehab Management, 8 Sept 2006 [cached]
Faculty chairperson for the series is internationally recognized cancer research expert, Jacob M. Rowe, MD, Director of Hematology and Bone Marrow Transplantation, Rambam Medical Center Technion, Israel Institute of Technology in Hafia, Israel.
WHITE PLAINS, NY - Patients with ..., 4 Oct 2007 [cached]
WHITE PLAINS, NY - Patients with acute myelogenous leukemia (AML) can learn about treatment options during a free Society teleconference led by leukemia expert Jacob M. Rowe, M.D., of the Israel Institute of Technology.
Acute Myelogenous Leukemia (AML): Understanding Treatment Approaches is scheduled for Thursday, Oct. 18, 1 p.m. - 2 p.m. ET.Dr. Rowe is director, Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center Technion, Israel Institute of Technology.He will discuss treatment choices, current AML therapies, the role of clinical trials and quality-of-life issues.
Israel Cancer Association USA Honors Dr. Jacob Rowe of Rambam Medical Center in Haifa for Stem Cell Transplant Research, 13 Dec 2004 [cached]
Palm Beach, FL (PRWEB) February 1, 2006 -- The Israel Cancer Association USA Annual Gala 2006 will be honoring Dr. Jacob M. Rowe of the Rambam Medical Center in Haifa on Palm Beach as the recipient of the Emanuel G. Rosenblatt Award for Scientific Achievement.On Thursday, February, 2, Dr. Rowe will be available for media interviews via phone prior to the Gala to discuss the impact that the Israel Cancer Association has had on his work and the opportunities afforded to him by generous donations from residents of Palm Beach.
This year's recipient is Dr. Jacob M. Rowe, Chief of the Department of Hematology and Bone Marrow Transplantation at the Rambam Medical Center in Haifa.
Dr. Rowe is responsible for establishing a major Stem Cell Transplant Unit at Rambam Medical Center and revitalized the Hematology Department, significantly improving the level of care for patients with Hematologic diseases.
Other People with the name "Rowe":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.